Dr Reddy’s faces Revlimid cliff, analysts split on future growth prospects
Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance ...
